Cancer Prevention Research
Overview
Cancer Prevention Research is a peer-reviewed scientific journal that focuses on cutting-edge research in the field of cancer prevention. It publishes original studies, reviews, and commentaries that explore various strategies, including lifestyle modifications, chemoprevention, and immunoprevention, aimed at reducing the risk of cancer development. The journal serves as a valuable resource for researchers, clinicians, and policymakers dedicated to advancing our understanding of cancer prevention and improving public health outcomes.
Details
Details
Abbr.
Cancer Prev Res (Phila)
Start
2008
End
Continuing
Frequency
Twenty-four no. a year, 2009-
p-ISSN
1940-6207
e-ISSN
1940-6215
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 2538
112
SJR / Ranks: 2696
1239
CiteScore / Ranks: 4374
5.50
JIF / Ranks: 3040
3.3
Recent Articles
1.
Jiang S, Bennett D, Colditz G
Cancer Prev Res (Phila)
. 2025 Mar;
PMID: 40066855
Screening digital breast tomosynthesis (DBT) aims to identify breast cancer early when treatment is most effective leading to reduced mortality. In addition to early detection, the information contained within DBT...
2.
Yuan J, Kensler T, Dacic S, Hartman D, Wang R, Balogh P, et al.
Cancer Prev Res (Phila)
. 2025 Mar;
PMID: 40041932
Experimental studies have shown dietary isothiocyanates reduced cellular proliferative marker Ki-67 and increased apoptotic markers Caspase-3 and TUNEL in animals, but human data are lacking. The present study was to...
3.
Zhu X, Chen R, Ness R, Naik R, Murff H, Zhang H, et al.
Cancer Prev Res (Phila)
. 2025 Mar;
PMID: 40034042
Aspirin reduces colorectal cancer risk but has a potential for adverse effects. Recent pre-clinical data suggest that intermittent dosing of aspirin may minimize adverse effects maintaining efficacy. We conducted a...
4.
5.
Nagykaldi Z, Doescher M, Rhoades D, Dwyer K, Chou A, Gibson M
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 40018805
The Tribally-Engaged Approaches to Lung Cancer Screening (TEALS) study aimed to co-design and test a community-based lung cancer screening (LCS) program within a large, tribally operated health system. In 2020-2021,...
6.
Moussa M, Fan N, Birk J, Provatas A, Mehta P, Hatano Y, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39995164
Diet affects cancer risk and plant-derived polyphenols exhibit cancer-preventive properties. Walnuts are an exceptional source of polyphenolic ellagitannins, converted into urolithins by gut microflora. This clinical study examines the impact...
7.
Tadesse D, Rothman N, Xie S, Hurwitz L, Friesen M, Baris D, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39995157
The New England Bladder Cancer Study (NEBCS) has recently reported an increased bladder cancer risk with occupational exposure to mononuclear aromatic organic solvents, including exposure to benzene, toluene, and xylene...
8.
Benevolo M, Giuliani M, Rossi P, Rollo F, Giuliani E, Stingone C, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39936264
The International Anal Neoplasia Society (IANS) has generated recommendations for anal cancer screening, identifying MSM living with HIV (MSM-LWH) ≥35 years and MSM-noHIV ≥45 years as groups to prioritize. Since...
9.
Yeh P, Haas A, Sun C, Lu K, Meyer L, Toumazis I
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39930864
Levonorgestrel-releasing intrauterine system (LNG-IUS) use is approved by the FDA for contraception and heavy menorrhagia. More importantly, it effectively treats endometrial hyperplasia, a precursor to endometrial cancer. Thereby, LNG-IUS use...
10.
Wilechansky R, Challa P, Han X, Hua X, Manning A, Corey K, et al.
Cancer Prev Res (Phila)
. 2025 Feb;
PMID: 39916630
Despite increasing incidence of hepatocellular carcinoma (HCC) in vulnerable populations, accurate early detection tools are lacking. We aimed to investigate the associations between pre-diagnostic plasma metabolites and incident HCC in...